Form 4 for AXGN Axogen, Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-10 · accession 0000805928-25-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-13 | 2025-11-10+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $8.14 | +22.8K | 3,691 | New | +$185.7K |
| DM | 2025-11-13 | 2025-11-10+ | AXGN | Burke William P. Mr. | Dir | S - Sale+OE | $24.01 | -22.8K | 100 | -100% | -$547.9K |
| DM | 2025-11-13 | 2025-11-10+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $0.00 | -22.8K | 3,591 | -86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 19,227 | $8.14 | 19,327 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-11 | M | A | 3,591 | $8.14 | 3,691 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-11 | S | D | 3,591 | $24.02 | 100 | D | — | — | (F2) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.13 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-11-10 | S | D | 19,227 | $24.01 | 100 | D | — | — | (F1) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.10 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to purchase) | 2025-11-11 | M | D | 3,591 | $0.00 | 0 | D | $8.14 · — to 2032-07-11 | 3,591 Common Stock | (F3) This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022. |
| 6 | Derivative | Stock Option (right to purchase) | 2025-11-10 | M | D | 19,227 | $0.00 | 3,591 | D | $8.14 · — to 2032-07-11 | 19,227 Common Stock | (F3) This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022. |